These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6170670)

  • 1. Studies of defective tolerance in murine lupus.
    Laskin CA; Taurog JD; Smathers PA; Steinberg AD
    J Immunol; 1981 Nov; 127(5):1743-7. PubMed ID: 6170670
    [No Abstract]   [Full Text] [Related]  

  • 2. NZB cells actively interfere with the establishment of tolerance to BGG in radiation chimeras.
    Laskin CA; Smathers PA; Lieberman R; Steinberg AD
    J Immunol; 1983 Sep; 131(3):1121-5. PubMed ID: 6193177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular basis for resistance to induction of tolerance in BXSB SLE male mice.
    Hang L; Izui S; Slack JH; Dixon FJ
    J Immunol; 1982 Aug; 129(2):787-9. PubMed ID: 6177783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of systemic lupus erythematosus--studies using disease models. 2. Suppression of anti-ds DNA antibody formation in NZB/W mice and improvement of glomerulonephritis].
    Okuhira H; Terada E; Fukuda K; Ogita T; Miyamoto A
    Nihon Rinsho; 1984 Dec; 42(12):2795-800. PubMed ID: 6530764
    [No Abstract]   [Full Text] [Related]  

  • 5. Defective B cell tolerance induction in New Zealand black mice. I. Macrophage independence and comparison with other autoimmune strains.
    Goldings EA
    J Immunol; 1983 Dec; 131(6):2630-4. PubMed ID: 6196392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of oral tolerance in NZB/W female mice: relationship of antibodies to dietary antigens in human systemic lupus erythematosus.
    Carr RI; Tilley D; Forsyth S; Sadi D
    Adv Exp Med Biol; 1987; 216A():751-7. PubMed ID: 2446475
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of the multiple factors in the pathogenesis of autoimmunity in New Zealand mice.
    Steinberg AD; Klassen LW; Raveche ES; Gerber NL; Reinertsen JL; Krakauer RS; Ranney DF; Gershwin ME; Williams GW; Kovacs K; Reeves JP
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S190-201. PubMed ID: 27199
    [No Abstract]   [Full Text] [Related]  

  • 8. Malononitrilamides prevent the development of murine systemic lupus erythematosus-like diseases in BDF1 hybrid mice and MRL/lpr autoimmune mice.
    Schorlemmer HU; Brendel S; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3040-2. PubMed ID: 8962180
    [No Abstract]   [Full Text] [Related]  

  • 9. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences in ease of tolerance induction to bovine gamma-globulin: dependence on macrophage function.
    Lukić ML; Cowing C; Leskowitz S
    J Immunol; 1975 Jan; 114(1 Pt 2):503-6. PubMed ID: 46883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid protein (SAP) as a marker of autoimmune disease in mice.
    Ozmen L; Singer M; Garotta G
    J Biol Regul Homeost Agents; 1994; 8(3):92-8. PubMed ID: 7754795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endotoxins and lupic nephropathies].
    Fournie GJ; Lambert PH; Conte JJ
    J Urol Nephrol (Paris); 1975 Sep; 81(9):707-14. PubMed ID: 1214316
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease.
    van Rappard-Van der Veen FM; Kiesel U; Poels L; Schuler W; Melief CJ; Landegent J; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1814-20. PubMed ID: 6321591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S; Masuda K
    J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns.
    Hanson DG
    J Immunol; 1981 Oct; 127(4):1518-24. PubMed ID: 6168694
    [No Abstract]   [Full Text] [Related]  

  • 19. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic abnormalities of the autoimmune mouse, Palmerston North.
    Davidson WF
    J Immunol; 1982 Aug; 129(2):751-8. PubMed ID: 6282970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.